Medite Cancer Diagnostics, Inc.
MDIT
$0.00
$0.000.00%
| 09/30/2018 | 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -94.56% | -88.54% | -43.12% | -32.41% | 5,068.75% |
| Total Receivables | 23.21% | -13.66% | -51.69% | -66.34% | -58.29% |
| Inventory | 3.45% | -28.75% | -27.78% | -36.95% | -13.34% |
| Prepaid Expenses | 67.97% | 69.84% | 195.50% | 49.37% | 109.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -85.50% | -- | -- | -- | -- |
| Total Current Assets | -21.90% | -26.34% | -28.11% | -35.18% | 10.96% |
|
|
|||||
| Total Current Assets | -21.90% | -26.34% | -28.11% | -35.18% | 10.96% |
| Net Property, Plant & Equipment | -1.09% | 2.03% | 13.70% | 14.19% | -16.42% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.43% | -15.08% | -27.68% | 29.80% | 42.04% |
| Total Assets | -7.24% | -8.33% | -7.87% | -9.19% | 2.41% |
|
|
|||||
| Total Accounts Payable | -29.96% | -45.24% | 8.46% | -10.91% | 102.84% |
| Total Accrued Expenses | 5,845.95% | 3,007.34% | 0.00% | 2.54% | -98.60% |
| Short-term Debt | -- | -- | -- | -46.53% | 106.58% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 127.75% | -89.45% | -89.39% | -90.35% | -89.79% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 592.59% | -- |
| Total Other Current Liabilities | -- | -- | -- | 592.59% | -- |
| Total Current Liabilities | 8.13% | -51.42% | -44.16% | -48.52% | -41.47% |
|
|
|||||
| Total Current Liabilities | 8.13% | -51.42% | -44.16% | -48.52% | -41.47% |
| Long-Term Debt | 12.66% | 4,321.31% | 2,895.38% | 2,420.00% | 1,755.33% |
| Short-term Debt | -- | -- | -- | -46.53% | 106.58% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -32.65% | -32.65% | -32.65% | -25.94% | -0.14% |
| Total Liabilities | 1.83% | 7.34% | 14.01% | 6.64% | 12.78% |
|
|
|||||
| Common Stock & APIC | 28.15% | 34.32% | 38.49% | 46.76% | 52.10% |
| Retained Earnings | -95.64% | -156.31% | -310.30% | -492.12% | -1,486.61% |
| Treasury Stock & Other | -7.11% | -24.20% | 31.90% | 18.33% | -31.82% |
| Total Common Equity | -22.37% | -30.22% | -35.04% | -31.84% | -10.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -22.37% | -30.22% | -35.04% | -31.84% | -10.19% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -19.69% | -26.73% | -31.13% | -28.02% | -9.07% |
|
|
|||||
